Your browser doesn't support javascript.
loading
Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System.
Ben, Ângela J; Neyeloff, Jeruza L; de Souza, Camila F; Rosses, Ana Paula O; de Araujo, Aline L; Szortika, Adriana; Locatelli, Franciele; de Carvalho, Gabriela; Neumann, Cristina R.
Afiliação
  • Ben ÂJ; Department of Health Sciences, Faculty of Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands. a.jornadaben@vu.nl.
  • Neyeloff JL; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
  • de Souza CF; Faculty of Medicine, Universidade do Vale do Taquari, Lajeado, Brazil.
  • Rosses APO; Department of Social Medicine, Federal University of Pelotas, Pelotas, Brazil.
  • de Araujo AL; Telessaúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Szortika A; Ophthalmology Service, Hospital Moinhos de Vento, Porto Alegre, Brazil.
  • Locatelli F; Postgraduate Program in Epidemiology, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • de Carvalho G; Postgraduate Program in Epidemiology, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
  • Neumann CR; Postgraduate Program in Epidemiology, School of Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Appl Health Econ Health Policy ; 18(1): 57-68, 2020 02.
Article em En | MEDLINE | ID: mdl-31674001
ABSTRACT

OBJECTIVE:

To perform a cost-utility analysis of diabetic retinopathy (DR) screening strategies from the perspective of the Brazilian Public Healthcare System.

METHODS:

A model-based economic evaluation was performed to estimate the incremental costs per quality-adjusted life-year (QALY) gained between three DR screening strategies (1) the opportunistic ophthalmology referral-based (usual practice), (2) the systematic ophthalmology referral-based, and (3) the systematic teleophthalmology-based. The target population included individuals with type 2 diabetes (T2D) aged 40 years, without retinopathy, followed over a 40-year time horizon. A Markov model was developed with five health states and a 1-year cycle. Model parameters were based on literature and country databases. One-way and probabilistic sensitivity analyses were performed to assess model parameters' uncertainty. WHO willingness-to-pay (WHO-WTP) thresholds were used as reference (i.e. one and three times the Brazilian per capita Gross Domestic Product of R$32747 in 2018).

RESULTS:

Compared to usual practice, the systematic teleophthalmology-based screening was associated with an incremental cost of R$21445/QALY gained ($9792/QALY gained). The systematic ophthalmology referral-based screening was more expensive (incremental costs = R$4) and less effective (incremental QALY = -0.012) compared to the systematic teleophthalmology-based screening. The probability of systematic teleophthalmology-based screening being cost-effective compared to usual practice was 0.46 and 0.67 at the minimum and the maximum WHO-WTP thresholds, respectively.

CONCLUSION:

Systematic teleophthalmology-based DR screening for the Brazilian population with T2D would be considered very cost effective compared to the opportunistic ophthalmology referral-based screening according to the WHO-WTP threshold. However, there is still a considerable amount of uncertainty around the results.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oftalmologia / Programas de Rastreamento / Análise Custo-Benefício / Diabetes Mellitus Tipo 2 / Retinopatia Diabética Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oftalmologia / Programas de Rastreamento / Análise Custo-Benefício / Diabetes Mellitus Tipo 2 / Retinopatia Diabética Tipo de estudo: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies / Screening_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2020 Tipo de documento: Article